Lv1
40 积分 2024-01-03 加入
Inavolisib-Based Therapy in PIK3CA -Mutated Advanced Breast Cancer
3个月前
已完结
PI3K-mTOR信号通路抑制剂抗肿瘤研究新进展
3个月前
已完结
Lorlatinib in Tyrosine Kinase Inhibitor−Naive Advanced ROS1 -Positive Non−Small Cell Lung Cancer
3个月前
已完结
ATCMD-Bench: Agentic Traditional Chinese Medicine diagnosis benchmark for Large Language Models via multi-agent simulation
3个月前
已完结
Gedatolisib in combination with palbociclib and endocrine therapy in women with hormone receptor-positive, HER2-negative advanced breast cancer: results from the dose expansion groups of an open-label, phase 1b study
3个月前
已完结
Overall survival in patients with hormone receptor-positive, HER2-negative advanced breast cancer treated in a phase 1b trial evaluating gedatolisib in combination with palbociclib and endocrine therapy
3个月前
已完结
Dalpiciclib plus letrozole or anastrozole versus placebo plus letrozole or anastrozole as first-line treatment in patients with hormone receptor-positive, HER2-negative advanced breast cancer (DAWNA-2): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
3个月前
已完结
Bireociclib Plus Fulvestrant in Advanced Breast Cancer After Endocrine Progression
3个月前
已完结
皖公网安备34019202002308
